Mark A Hull Selected Research

Eicosapentaenoic Acid

6/2021	Correction to: Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega‑3 polyunsaturated fatty acid eicosapentaenoic acid.
1/2021	Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
12/2018	Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
1/2018	A novel bioactive derivative of eicosapentaenoic acid (EPA) suppresses intestinal tumor development in ApcΔ14/+ mice.
12/2016	Measurement of red blood cell eicosapentaenoic acid (EPA) levels in a randomised trial of EPA in patients with colorectal cancer liver metastases.
5/2016	Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.
1/2015	The Pharmacokinetic Profile of a New Gastroresistant Capsule Preparation of Eicosapentaenoic Acid as the Free Fatty Acid.
11/2014	Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota.
11/2014	Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
7/2013	A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark A Hull Research Topics

Disease

32	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2002
23	Neoplasms (Cancer) 04/2021 - 10/2002
13	Adenoma (Adenomas) 01/2022 - 10/2002
13	Carcinogenesis 04/2021 - 01/2002
9	Polyps 01/2022 - 10/2002
7	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2021 - 11/2005
6	Neoplasm Metastasis (Metastasis) 12/2016 - 09/2003
5	Inflammation (Inflammations) 11/2014 - 10/2002
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 01/2015
3	Obesity 01/2021 - 06/2008
2	Microsatellite Instability 01/2022 - 12/2016
2	Breast Neoplasms (Breast Cancer) 01/2020 - 11/2013
2	Crohn Disease (Crohn's Disease) 01/2019 - 01/2015
1	Melanoma (Melanoma, Malignant) 04/2021
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Hemorrhage 12/2018
1	Ataxia (Dyssynergia) 01/2018
1	Ulcerative Colitis 01/2015
1	Colitis-Associated Neoplasms 11/2014
1	Carcinoma (Carcinomatosis) 11/2013
1	Hypoxia (Hypoxemia) 02/2013
1	Adenomatous Polyps 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2012
1	Vascular Diseases (Vascular Disease) 02/2012
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 02/2012
1	Morbid Obesity 07/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2011
1	Stomach Neoplasms (Stomach Cancer) 10/2002
1	Villous Adenoma 10/2002

Drug/Important Bio-Agent (IBA)

14	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 07/2010
12	Eicosapentaenoic AcidIBA 06/2021 - 07/2010
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2003
7	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022 - 10/2002
7	Nonesterified Fatty Acids (NEFA)IBA 01/2018 - 07/2010
6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 10/2002
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2018 - 01/2012
5	ProstaglandinsIBA 02/2013 - 07/2004
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 11/2014
4	Proteins (Proteins, Gene)FDA Link 11/2005 - 01/2002
3	Dinoprostone (PGE2)FDA Link 01/2020 - 08/2004
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2006 - 09/2003
2	CateninsIBA 04/2021 - 01/2017
2	Calcibiotic Root Canal SealerIBA 04/2021 - 12/2016
2	15-hydroxyprostaglandin dehydrogenaseIBA 01/2020 - 02/2013
2	Formaldehyde (Formol)FDA Link 12/2016 - 01/2006
2	ParaffinIBA 12/2016 - 01/2006
2	Macrophage Migration-Inhibitory FactorsIBA 07/2011 - 11/2005
2	rofecoxib (Vioxx)FDA Link 01/2006 - 09/2003
2	Messenger RNA (mRNA)IBA 11/2005 - 07/2004
1	lysyllysine (Lys-Lys)IBA 04/2021
1	mouse lysozyme MIBA 04/2021
1	enhanced green fluorescent proteinIBA 04/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	CalciumIBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2020
1	Cetuximab (Erbitux)FDA Link 01/2019
1	Opiate AlkaloidsIBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	EicosanoidsIBA 01/2018
1	TP-252IBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2017
1	Muramidase (Lysozyme)IBA 01/2017
1	Biological ProductsIBA 12/2016
1	GuaiacIBA 12/2016
1	ChemokinesIBA 05/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2016
1	Pharmaceutical PreparationsIBA 04/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2016
1	Dietary Fats (Dietary Fat)IBA 11/2014
1	MicroRNAs (MicroRNA)IBA 11/2013
1	CarcinogensIBA 10/2013
1	InterleukinsIBA 10/2013
1	Type II Interleukin-4 ReceptorsIBA 10/2013
1	Fish OilsIBA 07/2013
1	Warfarin (Coumadin)FDA LinkGeneric 07/2013
1	Hydroxyprostaglandin Dehydrogenases (Hydroxyprostaglandin Dehydrogenase)IBA 02/2013
1	EnzymesIBA 02/2013
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2012
1	LeptinIBA 04/2011
1	Insulin-Like PeptidesIBA 04/2011
1	Insulin (Novolin)FDA Link 04/2011
1	AdipokinesIBA 04/2011
1	prostaglandin D2 receptorIBA 07/2004
1	Antineoplastic Agents (Antineoplastics)IBA 09/2003
1	Cyclooxygenase InhibitorsIBA 10/2002
1	Protein Isoforms (Isoforms)IBA 10/2002
1	Cyclooxygenase 1IBA 10/2002
1	beta CateninIBA 01/2002

Therapy/Procedure

11	Chemoprevention 12/2018 - 10/2002
8	Therapeutics 04/2021 - 08/2004
4	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2021 - 06/2008
3	Bariatric Surgery 11/2018 - 06/2008
1	Precision Medicine 12/2018
1	Colectomy 01/2018
1	Oral Administration 11/2014
1	Gastrectomy 01/2014
1	Tattooing 07/2010
1	Investigational Therapies (Experimental Therapy) 01/2006
1	Drug Therapy (Chemotherapy) 09/2003